Compare CDP & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDP | MMED |
|---|---|---|
| Founded | 1988 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | 1996 | 2026 |
| Metric | CDP | MMED |
|---|---|---|
| Price | $33.78 | $14.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $34.57 | $22.56 |
| AVG Volume (30 Days) | 875.4K | ★ 969.1K |
| Earning Date | 04-27-2026 | 06-03-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | ★ 8.94 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $763,923,000.00 | N/A |
| Revenue This Year | $1.18 | $15.99 |
| Revenue Next Year | $3.71 | $10.00 |
| P/E Ratio | $98.59 | ★ N/A |
| Revenue Growth | ★ 1.41 | N/A |
| 52 Week Low | $26.91 | $10.65 |
| 52 Week High | $34.78 | $17.86 |
| Indicator | CDP | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 59.45 | 54.60 |
| Support Level | $30.32 | $12.80 |
| Resistance Level | $34.78 | $15.74 |
| Average True Range (ATR) | 0.78 | 0.98 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 73.25 | 65.41 |
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.